Saint Maur des Fosses, France

Christophe Morin

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christophe Morin: Innovator in Neurodegenerative Disease Research

Introduction

Christophe Morin is a notable inventor based in Saint Maur des Fosses, France. He has made significant contributions to the field of neurodegenerative diseases, particularly through his innovative patent related to Parkinson's disease. His work has implications for drug development and screening processes.

Latest Patents

Morin holds a patent titled "Chemical model of a neurodegenerative disease, method for preparation and uses of same." This invention focuses on the use of pyridinium furosemide and its derivatives in creating a chemical model for neurodegenerative diseases, specifically Parkinson's disease. The patent outlines methods for preparation and potential applications in identifying drug candidates through screening tests.

Career Highlights

Throughout his career, Christophe Morin has been associated with prestigious institutions such as the Centre National de la Recherche Scientifique and the Université Paris Est Créteil Val de Marne. His work in these organizations has allowed him to advance research in neurodegenerative diseases and contribute to scientific knowledge in this critical area.

Collaborations

Morin has collaborated with notable colleagues, including Thierry Martens and Michaël Rivard. These partnerships have likely enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Christophe Morin's innovative contributions to the understanding and modeling of neurodegenerative diseases highlight his role as a key inventor in this field. His patent and collaborations reflect a commitment to advancing medical research and improving drug development processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…